| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |